PRGS PROGRESS SOFTWARE CORP
Information Technology · Russell 2000
Next earnings: Tue 19 Jan 2027 · estimated
What 9 analyst firms say about PROGRESS SOFTWARE CORP: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
8 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8043
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8050
Recent analyst activity · last 90 days
Our tracked history has 6 reports on PRGS from 5 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 1 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Jefferies raised its target from $34.00 (set 31 Mar 2026) to $40.00 on 25 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Citigroup | Fatima A Boolani | Buy | 16 Jul 2026 | 53.00 USD |
| DA Davidson | Lucky Schreiner | Buy | 2 Oct 2026 | 55.00 USD |
| Guggenheim | John DiFucci | Buy | 1 Jul 2026 | 83.00 USD |
| Jefferies | Brent Thill | Hold | 25 Sep 2026 | 40.00 USD |
| Oppenheimer | Ittai Kidron | Buy | 1 Jul 2026 | 50.00 USD |
| Wedbush | Daniel Ives | Buy | 31 Mar 2026 | 45.00 USD |
| Weiss Ratings | Unnamed analyst | — | 8 Oct 2026 | — |
| Yorkville Ives | Dan Ives | Buy | 7 Oct 2026 | 48.00 USD |
| Data feed RESEARCH | Research Team | Buy | 5 Oct 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:55 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.